Individuals suffering from depressive disorders display a greater incidence of hypertension
compared with the general population, despite reports of the association between …

The effectiveness of available neuropsychiatric drugs in the era of an increasing number of
patients is not sufficient, and the complexity of neuropsychiatric disease entities that are …

Purpose Some reports have described arterial hypertension (AH) in patients treated by
serotonin reuptake inhibitor (SRI) or serotonin-norepinephrine reuptake inhibitor (SNRI) …

Olanzapine is one of the most frequently used antipsychotic medications during pregnancy,
but information about its safety and adverse effects profile during pregnancy is scarce. We …

Abstract Study Objective To compare the risk of antihypertensive treatment intensification
(TI) and major adverse cardiovascular events (MACE) with the initiation of serotonin …

Purpose: Coronary artery disease is a major cause of morbidity and mortality in the United
States, representing the highest proportion of deaths due to cardiovascular disease …

Atomoxetine, a selective norepinephrine (noradrenaline) reuptake inhibitor, is an effective
medication in attention-deficit hyperactivity disorder with a generally well-tolerated adverse …

Dear Editor, the first antidepressant medication of the serotonin-norepinephrine reuptake
inhibitor class is venlafaxine (effexor), which is taken orally with a half-life of 5 hours; …

Metabolic syndrome represents one of the major health, social and economic issues
nowadays, and affects more than 25% people worldwide. Being a multifactorial health …

A case report. The authors describe TLVH/T in a 30-year-old female with a history of chronic
emotional stress and depression treated with venlafaxine (75 mg twice a day). She suffered …